When someone uses the term “adult stem cells” you might think that simply means stem cells from adults. However, it’s not that simple. The goal of today’s post is to help you get all the key facts about adult stem cells. This includes the different types of adult stem cells and their clinical potential. What […]
What are adult stem cells & their clinical applications? Read More »
Sometimes the recommended weekly stem cell reads are just a bunch of papers I find intriguing, but more often they include at least one or more things that are not necessarily “recommended”. Instead these are items that stimulate discussion and debate. Today’s post includes one such complicated area on cord MSCs related to COVID-19 plus
Weekly stem cell reads: Pew, cord cells for COVID, more Read More »
A firm called Utah Cord Bank has been in the news related to stem cell clinics over the past year or two. Now they have received an FDA Warning Letter for a variety of manufacturing issues. Utah Cord Bank Background In terms of some brief backstory, Utah Cord Bank first popped up on my radar
FDA warning to stem cell clinic supplier Utah Cord Bank Read More »
Cancer stem cells are one of the most interesting areas of research, intersecting the stem cell and cancer fields. Today’s weekly reads post highlights some new cancer stem cell articles along with some other interesting papers. I also note a recent weak stem cell clinical trial paper that is not a recommended read but is
Weekly reads: cancer stem cells & other pubs plus a puzzler Read More »
The FDA filed two suits against unproven stem cell clinic firms in 2018 seeking permanent injunctions against them including US Stem Cell in Florida and Cell Surgical Network, et al. here in California. There’s been a major new development in this story that I see as good news. Court rejects US Stem Cell clinic appeal
US Stem Cell clinic loses appeal, could impact pending Cali case? Read More »
The journal Stem Cells Translational Medicine has a long track record of publishing great work. I also have a lot of respect for the editors there and I’ve published there myself. But a few recent events have sparked concerns including over possible undisclosed conflicts of interest in some papers there about cord blood for autism.
Cord conflicts at the journal Stem Cells Translational Medicine Read More »
This was a busy week for me working on a grant due Friday and a bunch of other stuff including happily analyzing a bunch of data, but there were tons of interesting papers recently including on pluripotency. California stem cell clinic court case on in the background Along the way this week I was occasionally
Weekly reads: court case, cancer stem cells, skin, pluripotency, & more Read More »
Mere weeks into the COVID pandemic, stunning graphics began to appear depicting the path of devastation of SARS-CoV-2 through a human lung. It’s only recently that we’ve come to understand what, exactly, is happening on a cellular level. The new view is thanks to single-cell RNA-sequencing, which analyzes the abundance of messenger RNAs in individual
COVID Traps Alveoli Cells in a Curious Progenitor State, Squelching Lung Regeneration Read More »
Does it make any sense medically or scientifically to use stem cell therapy for pain or neuropathy? There isn’t much solid evidence that this is a good way to go. However, there’s a vast scope of research ongoing in this area. Stem cell clinics have been earning millions of dollars selling this idea too. The
Fact-check of stem cell therapy for pain & neuropathy Read More »
Stem cell clinic firm US Stem Cell has just had a major paper retracted. Two of the notable authors on that paper are US Stem Cell leader Kristin Comella and stem cell researcher Thomas Ichim, who was senior author. It’s not clear to me if Comella currently has a role in the firm or not.
Stem cell clinic US Stem Cell has key paper retracted Read More »